• Thu. Jul 25th, 2024

MolecuLight Appoints Nanomedix as a specialized Distributor in Sri Lanka

MolecuLight Logo (CNW Group/MolecuLight)

 MolecuLight Inc., the leader in point-of-care fluorescence imaging for detection of wounds containing elevated bacterial loads Nanomedix (PVT) LTD as the specialized Distributor in Sri Lanka for its i:X fluorescence wound imaging device.

‘Each Distributor and their commercial teams have been specially trained on the use and successful operation of the i:X and can support local demonstrations and training in their respective markets and in the appropriate local language. There is also a very strong tie to allow any Distributor or customer to access MolecuLight’s central team for special requests or support, to participate in our global publication and evidence-generation program and to share ideas for new product development’ aid Anil Amlani, MolecuLight’s CEO.

Each Distributor maintains a trained sales and clinical application support team that provides support to local MolecuLight customers via clinical demonstrations, by delivering MolecuLight’s comprehensive training program to new customers, and by supporting the ongoing adoption of the i:X device.

MolecuLight also maintains a direct Sales, Clinical Applications, and Technical Support team in the US and Canada.

MolecuLight’s first commercially released device, the MolecuLight i:X fluorescence imaging system and its accessories provide a point-of-care handheld imaging device for the global wound care market for the detection of wounds containing elevated bacterial burden (when used with clinical signs and symptoms) and for digital wound measurement. The company is also commercializing its unique fluorescence imaging platform technology for other markets with globally relevant, unmet needs including food safety, consumer cosmetics and other key industrial markets.

By Author

Leave a Reply

Your email address will not be published. Required fields are marked *